EUDA Health Holdings Limited

NASDAQ:EUDA

Medical - Care Facilities

Healthcare
$17.70 +14.19%

+$2.20 today

Market cap
$53.00M
Beta
0.59
P/E (TTM)
-7.9
EPS (TTM)
-$1.79
52W Low $5.26High $71.20

Volume 0.04M

Average 0.02M

EUDA Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

EUDA Health Holdings LimitedNASDAQ: EUDA

Net Receivables · Q2 FY2026 · quarter ended Jun 2026

Net receivables rises 73.3% from a year ago

Net receivables stood at $739.31K at the end of Q2 FY2026, up 73.3% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +20.1% a year.

Context

  • Net receivables amounted to 7.6% of total assets at the end of Q2 FY2026, down 12.5 pp from a year earlier.
  • Net receivables increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +73.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$739.31K+0.0% QoQ
Last fiscal yearDec 2025
$334.2K+96.3% YoY
Year agoJun 2025
$426.69K+73.3% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+73.3%——
1 year+96.3%——
3-year CAGR+20.1%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
334.2K USD
Year-over-year change
+96.3%
4-year CAGR
-46.5%

Net Receivables vs competitors

How EUDA compares with its peers on the latest reported figures

  • Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +73.3% is the 2nd highest of 7, against a peer median of -20.5%.
  • Net receivables amounts to 7.6% of total assets for EUDA, versus a peer median of 2.8%.
EUDA Competitors
Net Receivables for EUDA and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
FONRFONAR CorporationMar 2026$88.99M USD+9.0%+7.7%40.6%
AMWLAmerican Well CorporationMar 2026$57.09M USD-20.7%-5.2%17.5%
HYPRHyperfine, Inc.Mar 2026$5.8M USD-20.2%+27.7%9.6%
DTILPrecision BioSciences, Inc.Mar 2026$4M USD+99900.0%—2.8%
EUDAEUDA Health Holdings LimitedJun 2026$739.31K USD+73.3%+20.1%7.6%
ATYRaTyr Pharma, Inc.Mar 2026$477K USD-51.7%-58.0%0.6%
ZTEKZentek Ltd.Mar 2026CA$372.21K CAD-69.1%+286.3%2.5%
GUTSFractyl Health, Inc. Common StockMar 2026$0 USD——0.0%
Peer median (excluding EUDA) —-20.5%+7.7%2.8%

Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents190K57.54K189.01K237.61K345.15K
Short-term Investments00000
Net Receivables4.09M192.85K239.19K170.27K334.2K
Inventory0648.16K0128.98K2.84K
Other Current Assets2.8K24.12M295.25K226.03K357.18K
Total Current Assets4.35M25.03M723.44K762.88K1.04M
Property, Plant & Equipment (Net)161.16K124.5K206.99K316.26K332.29K
Goodwill992.69K0000
Intangible Assets289.96K00337.3K161.43K
Long-term Investments2.2M0000
Tax Assets(2.2M)0032.4K0
Other Non-current Assets2.2M478.06K380.07K281.38K183.47K
Total Non-current Assets3.65M602.56K587.07K967.34K677.2K
Total Assets8M25.63M1.31M1.73M1.72M
Account Payables2.82M1.46M1.29K25.89K14.15K
Short-term Debt353.73K3.57M3.17M1.04M2.2M
Tax Payables307.34K186.15K208.66K085.52K
Deferred Revenue0(3.69M)0477.92K522.03K
Other Current Liabilities3.82M25.14M4.6M(624)125K
Total Current Liabilities7.32M29.12M8.72M4.14M5.84M
Long-term Debt00000
Deferred Tax Liabilities49.29K0076.7K81.08K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00032.4K0
Total Non-current Liabilities82.95K15.02K75.11K160.91K148.55K
Total Liabilities7.4M29.14M8.79M4.3M5.98M
Common Stock334.86K21.31M27.43M47.81M48.83M
Retained Earnings180.33K(24.7M)(34.74M)(50.1M)(52.87M)
Accumulated OCI6.04K(125.69K)(185.47K)(260K)(210.99K)
Other Stockholders Equity00000
Minority Interest78.82K13.48K16.62K(19.01K)(12.58K)
Total Equity600.05K(3.51M)(7.48M)(2.57M)(4.27M)
Total Debt462.31K3.63M3.37M1.27M2.4M
Net Debt272.31K3.57M3.19M1.04M2.06M

EUDA Health Holdings Limited

NASDAQ:EUDA

Intrinsic Alpha fair value

Locked

Current Price

$17.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.